Hypertrophic cardiomyopathy comorbid with coronary heart disease: 6-year follow-up
https://doi.org/10.15829/1560-4071-2018-9-48-53
Abstract
A clinical case presented, of 6-year follow-up of a patient with apical hypertrophic cardiomyopathy (HCMP) and angina syndrome. The challenges discussed, of differential diagnostics of HCMP and coronary heart disease (CHD) in patient with angina and repolarization disorder on ECG. Specifics of the case presented, was hyperdiagnostics of CHD at the onset of clinical presentation, and intact coronary arteries. In 6 years of follow-up this patient developed coronary lesions required the stenting of left anterior descending artery. Comorbid CHD in older age with apical CHD worsened clinical picture and underlined the issue of comorbidity in CHD and HCMP.
About the Authors
Е. A. Kovalevskaya
Pirogov Russian National Research Medical University of the Ministry of Health; City Clinical Hospital № 52 of Moscow Healthcare Department
Russian Federation
Competing Interests:
Russian Federation
Competing Interests:
Conflicts of Interest nothing to declare
N. S. Krylova
Pirogov Russian National Research Medical University of the Ministry of Health; City Clinical Hospital № 52 of Moscow Healthcare Department
Competing Interests:
Competing Interests:
Conflicts of Interest nothing to declare
N. G. Poteshkina
Pirogov Russian National Research Medical University of the Ministry of Health; City Clinical Hospital № 52 of Moscow Healthcare Department
Competing Interests:
Competing Interests:
Conflicts of Interest nothing to declare
D. V. Fettser
City Clinical Hospital № 52 of Moscow Healthcare Department
Competing Interests:
Competing Interests:
Conflicts of Interest nothing to declare
A. E. Vanyukov
City Clinical Hospital № 52 of Moscow Healthcare Department
Competing Interests:
Competing Interests:
Conflicts of Interest nothing to declare
References
1. Sorajja P, Ommen SR, Nishimura RA, et al. Adverse prognosis of patients with hypertrophic cardiomyopathy who have epicardial coronary artery disease. Circulation. 2003;108:23428. doi: 10.1161/01.CIR.0000097110.55312.BF
2. Shin DG, Son JW, Park JY, et al. Impact of Coronary Artery Anatomy on Clinical Course and Prognosis in Apical Hypertrophic Cardiomyopathy: Analysis of Coronary Angiography and Computed Tomography. Korean Circ J. 2015 Jan;45(1):38-43. doi: 10.4070/kcj.2015.45.1.38.
3. Elliott PM, Anastasakis A, Borger MA, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy European Heart Journal. 2014;35:2733-79.
4. Ageev FT, Gabrusenko SA, Postnov AYu, et al. Clinical guidelines for the diagnosis and treatment of cardiomyopathies (hypertrophic). Eurasian Journal of Cardiology. 2014;3:523. (In Russ.)
5. Belenkov YuN, Privalova EV, Kaplunova VYu. Hypertrophic cardiomyopathy. M GOETARMEDIA, 2011. p. 392 (In Russ.)
6. Maron BJ. The electrocardiogram as a diagnostic tool for hypertrophic cardiomyopathy: revisited. Ann Noninvasive Electrocardiol. 2001;6:277-9.
7. Argulian E, Chaudhry FA. Stress testing in patients with hypertrophic cardiomyopathy. Prog Cardiovasc Dis. 2012 May-Jun;54(6):477-82. doi: 10.1016/j.pcad.2012.04.001.
8. Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124:783-831.
Review
For citations:
Kovalevskaya Е.A., Krylova N.S., Poteshkina N.G., Fettser D.V., Vanyukov A.E. Hypertrophic cardiomyopathy comorbid with coronary heart disease: 6-year follow-up. Russian Journal of Cardiology. 2018;(9):48-53. (In Russ.) https://doi.org/10.15829/1560-4071-2018-9-48-53
Views:
1383
Email this article 